학술논문
1739P Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: Analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1332-S1332
Subject
Language
ISSN
0923-7534